University of North Carolina, Chapel Hill
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of North Carolina, Chapel Hill sits in the top decile of US sponsors by registered trial count (#28 of 15,742 sponsors by registered trial count).
University of North Carolina, Chapel Hill: 1,109 sponsored US clinical trials, 108 recruiting.
University of North Carolina, Chapel Hill sponsors 1,109 registered US clinical trials on ClinicalTrials.gov, 108 of them currently recruiting, and 881 completed. 69 of these trials are in Phase 3-4 (later-stage) and 203 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.
Top-decile sponsor footprint
University of North Carolina, Chapel Hill ranks in the top decile of sponsors by registered trial count (#28 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
881 of 962 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,109 total, page 20 of 23
Oral Metolazone and Intermittent Intravenous Furosemide Versus Continuous Infusion Furosemide in Acute Heart Failure
NCT00904488
Pharmacokinetic Study of Raltegravir in Healthy Premenopausal Women.
NCT00746499
Behavioral Depression Treatment for African American HIV-infected Substance Users
NCT01351454
Treatment for Periodontal Disease in Dialysis Patients
NCT00937976
Effectiveness of Metformin Compared to Insulin in Pregnant Women With Mild Preexisting or Early Gestational Diabetes
NCT00835861
Genotype-Guided Warfarin Therapy Trial
NCT00904293
Once Weekly Subcutaneous Ports for the Administration of Anticoagulants
NCT00774748
Range of Neutrophil Response to 20,000 EU of Clinical Center Reference Endotoxin in Otherwise Healthy Smokers
NCT00753870
Long-term Lung Function and Disease Progression in Children With Early Onset Primary Ciliary Dyskinesia Lung Disease
NCT00722878
Continuous Oral Contraceptive Treatment in Premenstrual Dysphoric Disorder (PMDD)
NCT00927095
Validation of PROMIS Banks With COPD Exacerbations
NCT00784342
A Randomized Controlled Trial (RCT) of Carbon Dioxide Versus Air Insufflation During Endoscopic Retrograde Cholangiopancreatography (ERCP)
NCT00685386
Hemostatic Textile to Control Bleeding at Donor Graft Sites
NCT00855569
Effect of Gamma Tocopherol Supplementation on Neutrophil Response to 20,000 EU of Clinical Center Reference Endotoxin in Normal Adults
NCT00631085
HIV Treatment-Readiness Measure (HTRM) Validation
NCT00686049
Improving Representative Payeeship for People With Psychiatric Disabilities and Their Families
NCT00924976
Ciprofloxacin for the Prevention of Postoperative Endoscopic Recurrence in Crohn's Disease
NCT00609973
Study in Healthy Males to Measure Maraviroc in Blood, Saliva, Seminal Fluid, and Rectal Tissue
NCT00775294
Safety Study of 20,000 EU of Clinical Center Reference Endotoxin in Allergic Adults With and Without Mild Asthma
NCT00630461
Nurture: A Program for Mothers With Histories of Disordered Eating
NCT00877994
Online Cognitive Behavioral Therapy for Bulimia Nervosa
NCT00877786
UCAN: Uniting Couples in the Treatment of Anorexia Nervosa
NCT00928109
Time to Conceive: A Study of Fertility
NCT01028365
Integrated Treatment of Marijuana Abuse for HIV+ Youth
NCT00683488
Linkage to Care - Part I
NCT00703040
Psychosocial Needs of YMSM
NCT00710671
Myfortic Conversion Trial in OLT Recipients With GI Intolerance
NCT00619216
Trial of a Water Beverage Intervention for Promoting Modest Weight Reduction in Free Living Adults
NCT01017783
Feasibility Study of Vessel Analysis for Noninvasive Diagnosis of Malignancy in Breast Tumors
NCT00630292
Impact of a Human Papilloma Virus (HPV) Vaccine in HIV-Infected Young Women
NCT00710593
Development of a Questionnaire to Measure Hypervigilance for Visceral Pain
NCT01166802
Open Label Seroquel (Quetiapine) Study for Treatment Resistant Functional Bowel Disorder
NCT00617396
Lubiprostone Effects on Visceral Pain Sensitivity
NCT01166789
Child Care Wellness Study on Nutrition and Physical Activity
NCT01921842
Effects of Diesel Exhaust Followed by Administration of Nasal Spray Flu Vaccine on Individuals With & Without Allergies
NCT00617110
A Study of Sublingual Immunotherapy in Peanut-allergic Children
NCT00597727
Third Molar Clinical Trials: Pericoronitis Studies
NCT01882270
Pounds Off Digitally Study: A Podcasting Weight Loss Intervention
NCT00771095
The Effects of a Self-management Intervention on Low Literacy Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT01327456
Efficacy of Cantharidin in Molluscum Contagiosum
NCT00667225
Feasibility and Effects of Preventive Home Visits for Older Adults
NCT00985283
Vitamin D Reabsorption in Adolescents and Young Adults With HIV Infection
NCT00490412
Neurocognitive Assessment in Youth Initiating HAART
NCT00683579
Epigenetics, DNA Methylation Patterns and Periodontal Disease
NCT01399034
Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r)
NCT00491556
Characterization of Interferon Beta -1b-Induced Tolerizing Effect in Dendritic Cells
NCT00630721
Microbicides Acceptability Among Sexually Active Young Women
NCT00490152
Effect of Antipsychotics on Appetite Regulation
NCT00903916
Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors
NCT00701844
Human Requirements for the Nutrient Choline
NCT00065546
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 111 |
| Phase 2 | 92 |
| Phase 3 | 13 |
| Phase 4 | 56 |
Therapeutic Areas
What is open in the University of North Carolina, Chapel Hill pipeline
108 recruiting of 1,109 indexed (10% open); 881 completed (79%).
Phase mix: 69 late (III/IV) vs 203 early (I/II) (early-phase heavy).
Top condition: Obesity (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of North Carolina, Chapel Hill: open-pipeline peers nationwide
Peers matched on 1,109 registered trials and 10% open enrollment, not the therapeutic-area sidebar.
University of North Carolina, Chapel Hill sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,109 trials (± recruiting share)
- University of Florida · 1,106 trials · 15% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
Sponsors near 10% open enrollment (± trial volume)
- Children's Hospitals and Clinics of Minnesota · 10% recruiting · 31 trials
- Cytokinetics · 10% recruiting · 31 trials
- Sanofi · 10% recruiting · 713 trials
- Ohio University · 10% recruiting · 51 trials
Related
What to do with this University of North Carolina, Chapel Hill page
1,109 registered trials is a research-attention snapshot, not an endorsement of University of North Carolina, Chapel Hill or any single study.
- 108 of University of North Carolina, Chapel Hill's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of North Carolina, Chapel Hill studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of North Carolina, Chapel Hill pipeline card: 1,109 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.